| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $8.97B | +23.8% |
| Cost of Revenue | $1.92B | +22.1% |
| Gross Profit | $7.05B | +24.3% |
| R&D Expense | $2.12B | +20.1% |
| SG&A Expense | $863.0M | +17.4% |
| Operating Income | $762.0M | +114.6% |
| Pre-tax Income | $1.01B | +152.6% |
| Income Tax | -$723.0M | -1077.0% |
| Net Income | $1.73B |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.90B | +29.0% |
| Accounts Receivable | $2.04B | +18.0% |
| Current Assets | $7.78B | +16.9% |
| Total Assets | $17.39B | +30.7% |
| Current Liabilities | $7.37B | +22.6% |
| Total Liabilities | $9.76B | +18.0% |
| Stockholders' Equity | $7.63B | +51.6% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $3.40B | +24.8% |
| Capital Expenditures | $694.0M | +26.2% |
| Investing Cash Flow | -$2.17B | +16.1% |
| Financing Cash Flow | -$803.0M | -133.4% |
| Free Cash Flow | $2.70B | +24.4% |
| +432.6% |
| EPS (Basic) | $8.48 | +426.7% |
| EPS (Diluted) | $8.42 | +426.3% |